Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/27/23
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 11/06/20
End: 10/30/22
Due: 10/30/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs | NCT06329908 | Zhen-Yu Ding | user2@example.com | None | 2023-09-27 | 2026-10-31 | 2027-10-31 | - | - | 2025-07-14 |
| A Phase II Study on Dose Optimization of Fruquintinib in Elderly mCRC Patients Refractory to Standard Treatment（DOFEMCRC） | NCT05025631 | Zhen-Yu Ding | user2@example.com | None | 2020-11-06 | 2022-10-30 | 2023-10-30 | - | - | 2025-07-14 |